Results 161 to 170 of about 58,115 (295)

Joint Clinical Assessment in the EU HTA Regulation-Would Drugs Supported by Single-Arm Trials Fit Under Evaluation? [PDF]

J Mark Access Health Policy
Kloc K, Toumi M, Łukomska E, Kowalska M, Tyrała-Chowaniec I, Simoens S, Wasem J, Boyer L, Dussart C, Auquier P.   +9 more
europepmc   +1 more source

The Credit Rating Agencies: An Analysis Through the Lenses of Industrial Organization, Finance, and Regulation

, 2016
Lawrence J. White
openalex   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Balancing benefit and risk in early Alzheimer's disease: the European Medicines Agency (EMA) assessment of lecanemab and donanemab. [PDF]

Lancet Reg Health Eur
Guizzaro L, Bałkowiec-Iskra E, Haberkamp M, Mol PGM, Moreau A, Mueller-Berghaus J, Philadelphy D, Balabanov P, Garcia J, Thirstrup S, Sepodes B.   +10 more
europepmc   +1 more source

SPECIFICS OF THE ANALYSIS PERFORMED BY CREDIT AGENCIES TO DETERMINE CREDIT RISK AND CREDIT RATING IN ASSESSING THE CREDITWORTHINESS OF ENTERPRISES

, 2022
Гергана Цончева-Петкова
openalex   +1 more source

Translating whole‐genome doubling into precision medicine in cancer

Molecular Oncology, EarlyView.
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley   +1 more source

Ratings agencies and their influence on insurance market

, 2008
Александр Николаевич Залетов
openalex   +1 more source

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

Molecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Safe Minimum Nurse Staffing Requirements for Hospitals: Evidence From Pennsylvania. [PDF]

Med Care
Muir KJ, Aiken LH, Brom H, Hovsepian V, Lasater KB, McHugh MD.   +5 more
europepmc   +1 more source

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

Molecular Oncology, EarlyView.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu, Puspa Das, Xing Zhang, Xiaodong Cheng   +3 more
wiley   +1 more source